RSCM
CERE
Rock Springs Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-547,946
| Closed | -$23.2M | – | 119 |
|
|
2024
Q1 | $23.2M | Sell |
547,946
-2,126,299
| -80% | -$89.9M | 0.59% | 53 |
|
|
2023
Q4 | $113M | Buy |
2,674,245
+145,129
| +6% | +$6.15M | 2.79% | 9 |
|
|
2023
Q3 | $55.2M | Buy |
2,529,116
+15,200
| +0.6% | +$332K | 1.48% | 23 |
|
|
2023
Q2 | $79.9M | Hold |
2,513,916
| – | – | 1.9% | 15 |
|
|
2023
Q1 | $61.3M | Buy |
2,513,916
+7,452
| +0.3% | +$182K | 1.46% | 23 |
|
|
2022
Q4 | $79.1M | Buy |
2,506,464
+7,316
| +0.3% | +$231K | 1.9% | 18 |
|
|
2022
Q3 | $70.6M | Buy |
2,499,148
+732,007
| +41% | +$20.7M | 1.82% | 15 |
|
|
2022
Q2 | $46.7M | Buy |
1,767,141
+43,800
| +3% | +$1.16M | 1.36% | 26 |
|
|
2022
Q1 | $60.3M | Buy |
1,723,341
+74,906
| +5% | +$2.62M | 1.52% | 22 |
|
|
2021
Q4 | $53.4M | Buy |
1,648,435
+47,846
| +3% | +$1.55M | 1.23% | 29 |
|
|
2021
Q3 | $47.2M | Buy |
1,600,589
+583,644
| +57% | +$17.2M | 0.99% | 34 |
|
|
2021
Q2 | $26.1M | Buy |
1,016,945
+11,845
| +1% | +$303K | 0.51% | 61 |
|
|
2021
Q1 | $13.8M | Buy |
1,005,100
+6,100
| +0.6% | +$83.8K | 0.3% | 92 |
|
|
2020
Q4 | $16.6M | Buy |
+999,000
| New | +$16.6M | 0.35% | 88 |
|